GASTRIC-CANCER AND PREMALIGNANT LESIONS IN ATROPHIC GASTRITIS - A CONTROLLED TRIAL ON THE EFFECT OF SUPPLEMENTATION WITH ALPHA-TOCOPHEROL AND BETA-CAROTENE
K. Varis et al., GASTRIC-CANCER AND PREMALIGNANT LESIONS IN ATROPHIC GASTRITIS - A CONTROLLED TRIAL ON THE EFFECT OF SUPPLEMENTATION WITH ALPHA-TOCOPHEROL AND BETA-CAROTENE, Scandinavian journal of gastroenterology, 33(3), 1998, pp. 294-300
Background: Vitamin E and beta-carotene are considered to decrease the
risk of gastric cancer both in humans and in laboratory animals. We s
tudied the effect of dietary supplementation with alpha-tocopherol and
beta-carotene on the end-of-trial prevalence of premalignant and mali
gnant lesions of the stomach in older men with atrophic gastritis. Met
hods: The study was carried out within the Alpha-Tocopherol, Beta-Caro
tene Cancer Prevention Study (ATBC study) in Finland, in which 29,133
male smokers aged 50-69 years were randomly assigned to receive daily
50 mg alpha-tocopherol, 20 mg beta-carotene, both of these agents, or
placebo, for 5-8 years. Serum pepsinogen was determined at base line a
nd after 3 years' supplementation to find men with atrophic gastritis.
A low serum pepsinogen I level, indicating atrophic gastritis of the
the corpus area of the stomach, was found in 2132 men. These men were
invited to have upper gastrointestinal endoscopy (gastroscopy), which
was performed on 1344 subjects after a median supplementation time of
5.1 years. Results: Neoplastic alterations were found in 63 of the men
(4.7%): 42 with definite dysplasias of low grade (moderate dysplasia)
, 7 with definite dysplasias of high grade (severe dysplasia), 11 with
carcinomas (of which 7 were 'early' cancers), and 3 with carcinoid tu
mors. Neither alpha-tocopherol (relative risk, 0.98; 95% confidence in
terval, 0.57-1.69) nor beta-carotene (relative risk, 1.13; 95% confide
nce interval, 0.65-1.95) supplementation had any association with end-
of-trial prevalence of gastric neoplasias after adjustment for other p
ossible risk factors. The effect was not modified by base-line serum l
evel or dietary intake of vitamins, prevalence of Helicobacter pylori
infection, or other covariates. Conclusions: We thus conclude that sup
plementation with alpha-tocopherol or beta-carotene for 5 years has no
major impact on the occurrence of neoplastic changes of the stomach i
n older male smokers with atrophic gastritis.